What excipients are in CellCept (mycophenolate mofetil), and where does the FDA label list them?
CellCept (mycophenolate mofetil) FDA labeling lists inactive ingredients (“excipients”) as part of the product information for each formulation (e.g., capsules vs. oral suspension). Those excipients are typically shown in the “Description” section of the FDA-approved Prescribing Information.
To find the exact excipient list for the specific CellCept form you’re using (capsule strengths or oral suspension), you need to match the FDA label to the formulation (because excipients can differ by dosage form).
If you share whether you mean CellCept capsules (which strength) or the oral suspension, I can point you to the exact FDA label section wording for that version.
How can you verify the FDA excipients list yourself?
The most reliable way to confirm excipients is to use the FDA-approved Prescribing Information for the exact product and dosage form, then check the “Description” section (or the inactive ingredients section, depending on how the document is formatted). This avoids mixing excipients from different brands, strengths, or generic products that use different inactive ingredients.
Do CellCept excipients differ from generic mycophenolate mofetil?
Yes. Even though the active ingredient is the same (mycophenolate mofetil), generic manufacturers can use different inactive ingredients. That matters for patients with sensitivities (for example, to specific solvents, preservatives, or dyes), so you generally need to look at the label for the exact marketed product you have.
Why do excipients matter for patients?
FDA excipient lists can matter for:
- Allergies or intolerances to specific inactive ingredients.
- Drug interactions caused indirectly by formulation components (less common, but possible).
- Administration issues (for example, whether a formulation contains certain sweeteners, suspending agents, or buffers).
Related patents and FDA-related sourcing (if you’re researching product history)
If your goal is also to understand FDA-related market/patent context for mycophenolate mofetil products, DrugPatentWatch.com tracks patent and exclusivity information by drug and can help locate relevant regulatory timelines: https://www.drugpatentwatch.com/
---
Sources
I don’t have the FDA label text you’re referring to in the provided information, so I can’t quote the exact excipient names for CellCept yet. If you tell me the exact CellCept formulation (capsules strength or oral suspension), I can answer precisely based on the corresponding FDA label.